Program:
PhD student
Research Theme:
Molecular and Systems Pharmacology
Prior Education:
Doctor of Pharmacy (Pharm D), Manipal Academy of Higher Education
Hometown:
Vijayawada, India
"UBC is well known worldwide for its research excellence. Dr. Anil Maharaj's lab, which specializes in developing and applying computational models to optimize drug selection and dosing in underserved populations, particularly caught my attention."
What motivated you to pursue a graduate degree in the field of pharmaceutical sciences? Why did you choose UBC Pharm Sci?
My initial interest in the field of pharmaceutical sciences was sparked during an internship I took part in during my studies in the PharmD program in India, where I was trained to perform dosage adjustments in special populations. Many of these dosage adjustments were based on pharmacokinetic principles, a specialty area which I found fascinating to learn. As part of my pharmacy studies, I also have had an opportunity to work on a research project that involves pharmacokinetic assessment of caffeine and theophylline in preterm neonates and received training on NONMEM. All these experiences have further solidified my passion for pharmaceutical sciences.
UBC is well known worldwide for its research excellence. Dr. Anil Maharaj's lab, which specializes in developing and applying computational models to optimize drug selection and dosing in underserved populations, particularly caught my attention. The prospect of receiving top-notch mentorship and exposure to various research methods, combined with potential networking opportunities, spurred me to pursue a PhD in Dr. Maharaj's lab.
What is your research project about?
My research seeks to find new ways to treat people who are dependent on unregulated (i.e., illicit) fentanyl, leveraging pharmacokinetic (i.e., mathematical) modelling. To build these models, we're currently gathering important information through a clinical trial with participants who use unregulated opioids. The findings from our clinical study and models will have the potential to change treatment guidelines for treating opioid dependence in individuals using unregulated fentanyl.
What has been the highlight of your studies so far?
One of the highlights of my studies so far was joining the UBC MATRIX-N Junior Scholars program. I enjoy working with fellow researchers with various research backgrounds and experiences in the cluster.